enVVeno Medical Corp
NVNOCIK 0001661053
Revenue (TTM)
$187.33K
−83.3% YoY
Q1 May 2026
Net Income (TTM)
−$19.59M
+10.8% YoY
Q1 May 2026
EPS Diluted (TTM)
−$14.20
−2,503.1% YoY
Q1 May 2026
Gross Margin
27.3%
Q1 May 2026
Operating Margin
-11,182.2%
Q1 May 2026
Net Margin
-10,454.6%
Q1 May 2026
Free Cash Flow (TTM)
−$16.02M
Q1 May 2026
Cash
$2.6M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
667.67K sh
Q1 May 2026